Macitentan treatment retards the progression of established pulmonary arterial hypertension in an animal model()

BACKGROUND: Macitentan is a new endothelin receptor antagonist that is used to treat pulmonary arterial hypertension in humans. Treatment of established pulmonary hypertension with macitentan was studied using the monocrotaline model of pulmonary hypertension. METHODS: Three groups of rats were crea...

Descripción completa

Detalles Bibliográficos
Autores principales: Temple, I.P., Monfredi, O., Quigley, G., Schneider, H., Zi, M., Cartwright, E.J., Boyett, M.R., Mahadevan, V.S., Hart, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251701/
https://www.ncbi.nlm.nih.gov/pubmed/25305681
http://dx.doi.org/10.1016/j.ijcard.2014.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251701/
https://www.ncbi.nlm.nih.gov/pubmed/25305681
http://dx.doi.org/10.1016/j.ijcard.2014.09.005

Ejemplares similares